panCELLa provides stem cells as a source for “FailSafe(TM) off-the-shelf cell therapy” targeting degenerative, infectious and malignant diseases
ORIGIN
Learn about the origin of panCELLa’s patented technology and therapeutic cell products
CORE TECHNOLOGIES
panCELLa develops a variety of core technologies for medical and scientific purposes
LATEST NEWS & EVENTS

Author By panCELLaPosted on
panCELLa is honoured to be recognized by Life Sciences Review and one of the Top 10 Biotech Companies in Canada. https://www.lifesciencesreview.com/pancella...

Author By panCELLaPosted on
Over the past year panCELLa has enhanced its patent position and expanded access to its exclusive FailSafeTM and induced Allogeneic Cell Tolerance (iACT Stealth CellsTM ). panCELLa continues to accelerate cell-based...

Author By panCELLaPosted on
panCELLa, a privately held biotechnology company focused on developing safe therapeutic cell products for a broad range of diseases, is pleased to announce the issuance of the FailSafeTM patent in Japan. This patent is...